Skip to main content
. 2021 Oct 14;13(10):1685. doi: 10.3390/pharmaceutics13101685
AFM Atomic force microscopy
AMD Age Macular Degeneration
Anti-VEGFs Anti-vascular endothelial growth factors agents
ATR–FTIR Fourier transform infrared spectral analysis
β-CD β-cyclodextrin
CCB Celecoxib
CCCs Chitosan coated cubosomes
CCLs chitosan coated liposomes
CDs Cyclodextrins
CMCS Carboxymethyl chitosan
CNV Choroidal neovascularization (CNV)
Cs Chitosan
CSO Chitosan oligosaccharide
CVS Chitosan oligosaccharide-valylvaline-steric acid
DEX Dexamethasone
DR Diabetic Retinopathy
DDS Drug Delivery System
%EE % Entrapment Efficiency
FITC Fluorescein isothiocyanate isomer
GIT Gastrointestinal tract
HConEpiC Human conjunctival epithelial primary cells
HCEpiC Human Corneal Epithelial Primary Cells
HP-β-CD Hydroxypropyl β-cyclodextrin
HPMC Hydroxypropyl methylcellulose
IVT Intravitreal
LDH Inorganic materials of hydroxide
MEs microemulsions
MLVs multilamellar vesicles
NF Nepafenac
NLCs Nanostructured lipid carriers
NMR Nuclear magnetic resonance
OC-40 Octoxynol-40
OcDD Ocular drug delivery
PDT Photodynamic therapy
PEG Poly (ethylene glycol)
PepT-1 Peptide transporter-1
PGF Placental Growth Factors
P-gp P-glycoprotein
PLGA poly (lactic-co-glycolic acid)
PDS port delivery system
PS Particle size
PSEDs Posterior segment eye diseases
PVA Polyvinyl alcohol
PVA-R Polyvinyl alcohol derivatives bearing a hydrophobic anchor at the terminate molecule
SA Steric acid
TA Triamcinolone aetonide
TER Transepithelial electrical resistance
TPP Sodium tripolyphosphate
ULVs Unilamellar vesicles
VEGF Vascular Endothelial Growth Factors
VV Valyl valine
ZP Zeta potential